|

Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe

RECRUITINGSponsored by University of Michigan Rogel Cancer Center
Actively Recruiting
SponsorUniversity of Michigan Rogel Cancer Center
Started2023-10-16
Est. completion2026-10
Eligibility
Age40 Years – 80 Years
SexMALE
Healthy vol.Accepted
Locations1 site

Summary

In this project, we will integrate the Photoacoustic (PA) technology into a prostate biopsy procedure through a fine needle probe. The needle probe will be in the shape of a biopsy needle and compatible with the needle insertion mechanism in the transrectal ultrasound (TRUS) probe. When inserted into the prostate, the fine needle PA probe will assess the histological information in its surrounding tissue without any tissue extraction. The needle probe has been tested in prostate tissue samples and whole human prostates ex vivo.

Eligibility

Age: 40 Years – 80 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria:

* 1\) Planned prostate biopsy as part of routine clinical care
* 2\) \> 40 and \<80 years old

Exclusion Criteria:

* 1\) Known history of bleeding disorders or
* 2\) Patients taking anticoagulants, no matter doses or washout time
* 3\) Known allergy to silicone material
* 4\) Unable to provide informed consent
* 5\) Either the surgeon or the patient do not think the patient will not be able to complete all parts of the study, the patient will be excluded
* 6\) Involved in other investigational studies.

Conditions2

CancerProstate Cancer

Locations1 site

University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109
Cancer AnswerLine800-865-1125CancerAnswerLine@med.umich.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.